Tango Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tango Therapeutics (NASDAQ: TNGX), a clinical-stage biotechnology company focused on precision cancer medicines, has announced its participation in two upcoming investor conferences. Barbara Weber, M.D., President and CEO of Tango Therapeutics, will represent the company at these events:

1. 2024 Wells Fargo Healthcare Conference on September 4, 2024, at 12:45 PM ET in Boston, MA.

2. 2024 Cantor Global Healthcare Conference on September 17, 2024, at 9:10 AM ET in New York, NY.

Live webcasts of the presentations will be available on the company's website under the 'Events & Presentations' tab on the 'Investors' page. Replays will be archived for 90 days following each presentation.

BOSTON--(BUSINESS WIRE)-- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in the following upcoming investor conferences in September.

2024 Wells Fargo Healthcare Conference
Date: Wednesday, September 4, 2024
Time: 12:45 PM ET
Location: Boston, MA

2024 Cantor Global Healthcare Conference
Date: Tuesday, September 17, 2024
Time: 9:10 AM ET
Location: New York, NY

A live webcast of the presentations will be available under the "Events & Presentations" tab on the “Investors” page on the Company's website on the day of the event. A replay of the webcasts will be archived on the Company's website for 90 days following the presentation.

About Tango Therapeutics

Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Using an approach that starts and ends with patients, Tango leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. For more information, please visit www.tangotx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240828717768/en/

Investor Contact:

Sam Martin/Andrew Vulis

Argot Partners

tango@argotpartners.com

Media Contact:

Amanda Brown Galgay

SVP, Corporate Communications, Tango Therapeutics

media@tangotx.com

Source: Tango Therapeutics, Inc.

FAQ

When is Tango Therapeutics (TNGX) presenting at the 2024 Wells Fargo Healthcare Conference?

Tango Therapeutics (TNGX) is presenting at the 2024 Wells Fargo Healthcare Conference on Wednesday, September 4, 2024, at 12:45 PM ET in Boston, MA.

What is the date and time of Tango Therapeutics' (TNGX) presentation at the 2024 Cantor Global Healthcare Conference?

Tango Therapeutics (TNGX) is scheduled to present at the 2024 Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 9:10 AM ET in New York, NY.

Who will be representing Tango Therapeutics (TNGX) at the upcoming investor conferences?

Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics (TNGX), will be representing the company at the upcoming investor conferences.

How can investors access Tango Therapeutics' (TNGX) presentations at the upcoming conferences?

Investors can access live webcasts of Tango Therapeutics' (TNGX) presentations on the company's website under the 'Events & Presentations' tab on the 'Investors' page. Replays will be available for 90 days after each presentation.